Travere Therapeutics to Present at Upcoming Investor Conferences
May 08 2024 - 4:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that
company management will participate in the following upcoming
investor conferences:
BofA Securities Health Care
Conference Wednesday, May 15, 2024, at 8:00 a.m. PT
Jefferies Global Healthcare
ConferenceWednesday, June 5, 2024, at 3:00 p.m. ET
Live webcasts of the presentations will be
accessible on the Investor page of Travere’s website at
ir.travere.com/events-presentations. Replays will be available for
up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families, and caregivers of all backgrounds
as they navigate life with a rare disease. On this path, we know
the need for treatment options is urgent – that is why our global
team works with the rare disease community to identify, develop,
and deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Contact Info
|
Media:888-969-7879 mediarelations@travere.com |
Investors:888-969-7879 IR@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Apr 2024 to May 2024
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From May 2023 to May 2024
